Falls are a common and serious health concern for older adults, often leading to injuries, reduced independence, and a decline in quality of life. Understanding the various factors that contribute to falls and implementing effective prevention strategies are crucial for maintaining health and well-being in later years [1].
Understanding Fall Risk Factors
Several factors can increase an older adult's risk of falling. These include medical conditions, medications, and changes in physical abilities. For instance, older adults with multiple sclerosis (MS) may experience gait variability, which is a predictor of falls [2]. Even in healthy older adults, gait variability can indicate an increased likelihood of falls [2].
Atrial fibrillation (AF), a common heart rhythm disturbance in older adults, significantly increases the risk of stroke. While oral anticoagulants (OACs) are crucial for stroke prevention in AF, balancing their use with the risk of falls and potential bleeding is a complex clinical challenge [1, 7, 8]. This dilemma highlights the importance of careful assessment and shared decision-making between patients and their healthcare providers [1].
Surprisingly, a study found that neither lower blood pressure nor increased use of antihypertensive medications were associated with a greater concern about falling in older adults with hypertension [3]. However, a significant percentage of participants in this study reported mild (29.3%) to moderate or severe (17.9%) concern about falling at baseline [3].
The Role of Medication Management
Medications play a critical role in fall prevention, particularly for older adults with complex health needs. An interdisciplinary team, including a clinical pharmacist, can help review and adjust medication regimens to mitigate fall risk [1]. For example, in older adults with atrial fibrillation, direct oral anticoagulants (DOACs) are widely used for stroke prevention [5]. While these medications are effective, their use requires careful consideration, especially in very elderly patients who may have multiple comorbidities and be on several medications (polypharmacy) [5, 8].
Despite guidelines recommending OACs for stroke prevention in older adults with AF, these medications are often underused due to concerns about bleeding and falls [6, 7]. Family physicians consider a patient's risk of falls, bleeding, and stroke when deciding to initiate OACs, often using tools like CHADS2VASC and HASBLED to assess these risks [6]. Shared decision-making with patients is essential in these situations [1, 6].
Lifestyle and Physical Activity
Lifestyle modifications and regular physical activity are fundamental components of fall prevention strategies. Engaging in appropriate physical activity can improve balance, strength, and gait, thereby reducing the risk of falls [1]. For individuals with conditions like multiple sclerosis, understanding how gait variability under different walking conditions (single-task vs. dual-task) predicts falls can inform targeted physical therapy interventions [2]. For example, greater variability in stride length and swing time during walking has been linked to an increased risk of falls [2].
Interdisciplinary Care and Shared Decision-Making
An interdisciplinary approach involving various healthcare professionals is highly effective in assessing and mitigating fall risk [1]. This team may include a cardiologist, physical therapist, and clinical pharmacist, working together to develop a comprehensive care plan [1]. This collaborative model often utilizes frameworks like the Age-Friendly Health Systems 4Ms, which focuses on aligning care with what matters most to the older adult [1].
Shared decision-making is a cornerstone of this approach, especially when balancing the benefits of treatments like oral anticoagulants for stroke prevention with the risks of falls [1, 6]. This involves open discussions between patients, their families, and healthcare providers to ensure treatment plans reflect the patient's values and preferences [1]. Factors such as frailty, recurrent falls, and polypharmacy, while common in older adults with AF, are often overlooked and should be carefully considered in the decision-making process [8].
Addressing Specific Challenges in Older Adults
The aging population presents unique challenges in fall prevention due to increased comorbidities and polypharmacy [5, 8]. For instance, older adults in long-term care facilities with atrial fibrillation often have inconsistent use of oral anticoagulation, with a significant gap between indicated and prescribed therapies [4]. This highlights the need for better strategies to ensure appropriate stroke prevention in this vulnerable population [4]. While direct oral anticoagulants offer a safer and more convenient alternative to warfarin for many elderly patients with AF, careful consideration of individual patient factors remains paramount [7, 8].
Sources
- [1] Interdisciplinary Approach to Fall Risk Mitigation in an Older Adult with Atrial Fibrillation. https://pubmed.ncbi.nlm.nih.gov/41559530/
- [2] Gait variability predicts falls in older adults with multiple sclerosis. https://pubmed.ncbi.nlm.nih.gov/41385303/
- [3] Hypertension Treatment and Concern About Falling: Baseline Data from the Systolic Blood Pressure Intervention Trial. https://pubmed.ncbi.nlm.nih.gov/27640987/
- [4] The gap between indicated and prescribed stroke prevention therapies in a high-risk geriatric population. https://pubmed.ncbi.nlm.nih.gov/28091833/
- [5] Stroke Prevention With Oral Anticoagulants in High-Risk Atrial Fibrillation in an Aging Population. https://pubmed.ncbi.nlm.nih.gov/40347555/
- [6] Family Physician Prescribing Practices and Perspectives on Shared Decision-Making Regarding the Use of Oral Anticoagulants for Stroke Prevention in Patients 75 Years or Older With Atrial Fibrillation. https://pubmed.ncbi.nlm.nih.gov/36960556/
- [7] Antithrombotic Treatments for Stroke Prevention in Elderly Patients With Nonvalvular Atrial Fibrillation: Drugs and Doses. https://pubmed.ncbi.nlm.nih.gov/27568871/
- [8] Anticoagulation for Stroke Prevention in Older Adults with Atrial Fibrillation and Comorbidity: Current Evidence and Treatment Challenges. https://pubmed.ncbi.nlm.nih.gov/30238705/